–
Alzamend Neuro, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
millions USD
FY22:
FY23:
–
FY24:
–
FY25:
–
FY26:
–
(positive)
Change from FY22 to FY26
millions USD
FY22:
−12.3
FY23:
−14.9
FY24:
−9.94
FY25:
−4.50
FY26:
−8.77
(positive)
Change from FY22 to FY26
millions USD
FY22:
−12.3
FY23:
−14.8
FY24:
−9.89
FY25:
−4.45
FY26:
−8.66
(positive)
Change from FY22 to FY26
millions USD
FY22:
−12.4
FY23:
−14.9
FY24:
−9.95
FY25:
−4.51
FY26:
−8.77
(positive)
Change from FY22 to FY26
millions USD
FY22:
−12.4
FY23:
−14.9
FY24:
−9.95
FY25:
−4.51
FY26:
−8.77
All amounts in millions USD